Laboratory methods that detect or quantify specific antibodies or antigens in serum to assess exposure, immune response, vaccination status, or infection in animals; includes assays such as ELISA, agglutination tests, and immunofluorescence, and requires interpretation in the context of timing, vaccination history, and test characteristics.

Principle

Detection of pathogen‑specific antibodies indicates prior immune exposure or vaccination but does not always denote active infection; paired (acute and convalescent) sera demonstrating a significant rise in titre are more diagnostic of recent or ongoing infection than single samples, and antigen detection assays may indicate current presence of pathogen components.

Demonstration

Illustrative scenario: A dog suspected of viral infection has an acute serum sample collected at presentation and a convalescent sample two weeks later. Serologic testing shows a fourfold rise in specific antibody titre between samples, supporting recent infection and guiding isolation and treatment decisions. A single positive titre in isolation is interpreted in light of vaccination history.

Misapplication

Interpreting a single positive antibody titre as proof of active infection without considering prior vaccination, cross‑reactivity, or timing of sampling, or conflating antibody presence with pathogen viability. The semantic error is treating exposure markers as equivalent to active disease without temporal or complementary evidence.

Consequence

Appropriate serology can confirm exposure, support diagnosis when used as paired samples, guide vaccination and herd‑health decisions, and inform epidemiologic surveillance; misinterpretation can lead to unnecessary treatment, false reassurance, or incorrect conclusions about infectiousness or immunity.

Reversal

Serology is limited early in infection before seroconversion—direct detection methods (PCR, antigen tests, culture) are preferred for early or acute diagnosis—or when vaccination or cross‑reactive antibodies confound interpretation; in such contexts, direct pathogen assays or paired serology are necessary to resolve uncertainty.

Boundary

Clearly within: laboratory detection or quantification of antibodies or antigens in serum. Boundary case: rapid point‑of‑care serologic tests with lower sensitivity or specificity that require confirmatory laboratory assays. Clearly outside: molecular detection (PCR) of pathogen nucleic acid in clinical samples and antigen detection in non‑serum matrices without serologic correlation.

Semantic Tension

Trade‑off between population‑level surveillance and individual clinical diagnosis: serology excels for exposure assessment and epidemiology but has limitations for confirming acute infection in an individual without appropriate sampling strategy or complementary tests.

Synthesis

Serology is a powerful tool for assessing host exposure and immune status and for surveillance, but its correct clinical use depends on timing, vaccination history, and understanding test performance; it is most reliable when combined with direct pathogen detection or serial sampling to distinguish past exposure from active infection.